Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Osteoporosis Treatment Market?

The size of the osteoporosis treatment market has been expanding consistently over the past few years. It is projected to escalate from $13.96 billion in 2024 to about $14.62 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 4.8%. The surge observed in the historical period can be accredited to factors such as an ageing demographic, introduction of hormone replacement therapies, inclusion of calcium and vitamin D supplements, proliferation of diagnostic tools, and integration of digital health solutions.

What Growth Rate Is Forecasted for the Osteoporosis Treatment Market by 2029?

In the upcoming years, the osteoporosis treatment market is predicted to experience robust growth. It is projected to expand to $17.84 billion by 2029, with a compound annual growth rate (CAGR) of 5.1%. The uptick in the forecast period could be due to the increasing prevalence of sedentary lifestyles and secondary osteoporosis, the establishment of virtual bone fracture clinics, osteoporosis gene therapy, and a heightened emphasis on men’s bone health. Notable trends during the forecast period include the progression in biologics, incorporation of artificial intelligence and blockchain into bone health records, and the integration of machine learning.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12166&type=smp

Which Key Companies Are Shaping the Future of the Osteoporosis Treatment Market?

Major companies operating in the osteoporosis treatment market include Pfizer Inc., F. Hoffmann La Roche Ltd., Merck and Co Inc., AbbVie Inc., Novartis AG, GlaxoSmithKline Pharmaceutical Ltd., Takeda Pharmaceutical Company, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Asahi Kasei Corporation, AstraZeneca Plc., Viatris Inc., Teva Pharmaceuticals Industries Ltd., Daiichi Sankyo Company Ltd, Dr. Reddy’s Laboratories, Gedeon Richter Plc., Celltrion Inc., Luye Pharma Group, Ligand Pharmaceuticals Incorporated, Radius Health Inc., Haoma Medica Ltd., EffRx Pharmaceuticals SA

Which Factors Are Driving Demand in the Osteoporosis Treatment Industry?

The osteoporosis treatment market is expected to benefit from a surge in the prevalence and incidence of osteoporosis. Osteoporosis, a condition associated with changes in bone composition and strength or decreases in bone mass and mineral density, leads to the need for medications that reduce the speed at which bones degenerate. Hormonal treatments, such as estrogen, can contribute to preserving bone density, particularly if administered immediately post-menopause. Amgen, a biopharmaceutical firm based in the United States, projected in May 2022 that the yearly count of fractures caused by osteoporosis would rise by 68% to 3.2 million by 2040. Similarly, in April 2022, the National Library of Medicine, which is a US-based national resource for health practitioners, stated that an estimated 549,000 new fragility fractures are reported annually in the UK, with a third of these incidents involving men. As the population gets older, this figure is predicted to escalate by 19.6% by 2030. Consequently, the escalating prevalence and occurrences of osteoporosis are stimulating the growth of the osteoporosis treatment market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12166&type=smp

How Is the Osteoporosis Treatment Market Segmented by Several Divisions?

The osteoporosis treatment market covered in this report is segmented –

1) By Drug Type: Bisphosphonates, Calcitonin, Hormone Therapy, Selective Estrogen Receptor Modulators (SERMs), Parathyroid Hormone-Related Protein (PTHrP) Analog, Rank Ligand (RANKL) Inhibitor

2) By Route Of Administration: Oral, Injectable, Other Routes

3) By Distribution Channel: Hospitals, Retail Pharmacies And Stores, Online Pharmacies

Subsegments:

1) By Bisphosphonates: Alendronate, Risedronate, Ibandronate, Zoledronic Acid

2) By Calcitonin: Salmon Calcitonin, Synthetic Calcitonin Formulations

3) By Hormone Therapy: Estrogen Replacement Therapy, Combination Hormone Therapy (Estrogen And Progesterone)

4) By Selective Estrogen Receptor Modulators (SERMs), Raloxifene, Bazedoxifene

5) By Parathyroid Hormone-Related Protein (PTHrP) Analog: PTH Analog (Teriparatide), Other PTHrP Analogues

6) By Rank Ligand (RANKL) Inhibito: Denosumab

What are the Emerging Market Trends Driving the Growth of the Osteoporosis Treatment Industry?

Leading corporations in the osteoporosis treatment market are prioritizing the development of innovative injectable treatments to maintain their market dominance. Injectable therapies for osteoporosis are drugs delivered through injection aimed at preventing bone loss and minimizing the risk of fractures for osteoporosis sufferers. This approach directly enhances bone density and supports robust skeletal health. For example, Apotex Corp., a pharmaceutical company based in Canada, introduced a Teriparatide Injection in November 2023. The injection, meant for single-patient use, offers a novel solution for treating osteoporosis. Each pre-filled pen contains a 250 mcg/mL concentration, providing 28 daily doses of 20 mcg each. The aim of this product is to increase the accessibility of cost-effective treatments for the estimated 10 million Americans dealing with osteoporosis. The creation of this product reflects Apotex’s commitment to manufacturing intricate generic drugs, thereby ensuring patients have access to high-quality care.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/osteoporosis-treatment-global-market-report

Which Regions Are Driving Growth in the Osteoporosis Treatment Market?

North America was the largest region in the osteoporosis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the osteoporosis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12166

This Report Delivers Insight On:

1. How big is the osteoporosis treatment market, and how is it changing globally?

2. Who are the major companies in the osteoporosis treatment market, and how are they performing?

3. What are the key opportunities and risks in the osteoporosis treatment market right now?

4. Which products or customer segments are growing the most in the osteoporosis treatment market?

5. What factors are helping or slowing down the growth of the osteoporosis treatment market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model